Radiation therapy after surgery for early endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have endometrial adenocarcinoma (a type of cancer of the uterus lining) with a molecular type that is microsatellite unstable or low copy.
- Your cancer is stage IA grade 3 or stage IB (early stage), and has not spread into lymph-vascular spaces (small vessels).
- You have already had surgery to remove your uterus and both ovaries. Removal of lymph nodes is optional.
- You are generally able to take care of yourself (ECOG score 0-2).
- You start radiation therapy within 8 weeks after your surgery.
- Your blood counts are normal, and you do not have Crohn's disease or ulcerative colitis, or any prior cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation therapy (a newer technique called MH-ART versus a standard technique called CF-IMRT) given after surgery for cervical or endometrial cancer. The goal is to see which approach works better and causes fewer side effects.
This trial studies a new type of radiation therapy (called online adaptive radiotherapy) given in shorter, higher daily doses after surgery for high-risk endometrial cancer. The goal is to see if this approach is safe and effective for reducing side effects while still controlling the cancer.
This study compares different ways of giving radiation and chemotherapy after surgery for stage III endometrial (uterine) cancer. It aims to find which approach works best to reduce cancer risk and improve outcomes.
This trial tests a precise type of radiation (stereotactic radiotherapy) given after surgery for endometrial cancer. It aims to improve treatment while reducing side effects.
This study tests whether using genetic information (molecular classification) along with standard factors helps decide if you should have radiation after surgery for early-stage uterine cancer. It aims to improve treatment and reduce side effects.
This trial compares different “fractionation” schedules (how often and how many treatments) of vaginal brachytherapy radiation given after surgery for certain early-stage endometrial cancer. It may help find a plan that works well while aiming to control side effects.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.